why choose us

First received: October 25, 2023

Clinical Trial: Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neuropathy;Peripheral

Study Type: INTERVENTIONAL


Official Title: Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory

Brief Summary: To learn if a process called neuromodulation can help to improve pain due to CIP

Read more